Your browser doesn't support javascript.
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Diallo, Alpha; Trøseid, Marius; Simensen, Victoria Charlotte; Boston, Anaïs; Demotes, Jacques; Olsen, Inge Christoffer; Chung, Florence; Paiva, José Artur; Hites, Maya; Ader, Florence; Arribas, Jose Ramon; Baratt-Due, Andreas; Melien, Øyvind; Tacconelli, Evelina; Staub, Thèrèse; Greil, Richard; Tsiodras, Sotirios; Briel, Matthias; Esperou, Hélène; Mentré, France; Eustace, Joe; Saillard, Juliette; Delmas, Christelle; LeMestre, Soizic; Dumousseaux, Marina; Costagliola, Dominique; Røttingen, John-Arne; Yazdanpanah, Yazdan.
  • Diallo A; ANRS, Clinical Research Safety Department, France; INSERM, Clinical Research Safety Department, France.
  • Trøseid M; Oslo University Hospital, Department of Rheumatology, Dermatology and Infectious Diseases, Norway.
  • Simensen VC; Oslo University Hospital, Department of Research Support for Clinical Trials, Norway.
  • Boston A; Oslo University Hospital, Department of Rheumatology, Dermatology and Infectious Diseases, Norway.
  • Demotes J; ECRIN, Director General, France.
  • Olsen IC; Oslo University Hospital, Department of Research Support for Clinical Trials, Norway.
  • Chung F; Inserm Transfert SA, Department Collaborative Research Funding, France.
  • Paiva JA; Centro Hospitalar Universitário de São João, Department of Critical Care Medicine, Portugal.
  • Hites M; Erasmus Hospital, Infectious Diseases, Belgium.
  • Ader F; Hospices Civils de Lyon, Service de Maladies Infectieuses et Tropicales, France.
  • Arribas JR; La Paz University Hospital, Infectious Diseases Unit, Spain.
  • Baratt-Due A; Oslo University Hospital, Department of Immunology, Norway.
  • Melien Ø; Norwegian Institute of Public Health, Department of Assessment of Interventions, Norway.
  • Tacconelli E; University of Verona, Division of Infectious Diseases, University of Verona, Diagnostic and Public Health, Italy.
  • Staub T; Centre Hospitalier de Luxembourg, Maladies Infectieuses, Luxembourg.
  • Greil R; Paracelsus Medical University Salzburg, Laboratory of Immunological and Molecular Cancer Research, Austria.
  • Tsiodras S; National and Kapodistrian University of Athens - Faculty of Medicine, 4th Department of Internal Medicine, Greece.
  • Briel M; University Hospital Basel, Clinical Research, Switzerland.
  • Esperou H; INSERM, Pôle de Recherche Clinique, France.
  • Mentré F; Hôpital Bichat Claude-Bernard, Epidémiologie, biostatistique et recherche clinique, France.
  • Eustace J; University College Cork, Clinical Research, Ireland.
  • Saillard J; INSERM, Project Manager Clinical Microbiology and Infection, France.
  • Delmas C; INSERM, Pôle de Recherche Clinique, France.
  • LeMestre S; ANRS, Soutiens structurants à la recherche Gestion budgétaire et sites cliniques, France.
  • Dumousseaux M; INSERM, Project Manager, France.
  • Costagliola D; Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), France.
  • Røttingen JA; Norwegian Institute of Public Health, Division of Infectious Disease Control, Norway.
  • Yazdanpanah Y; INSERM, IAME, Hôpital Bichat - Claude-Bernard, Infectious Diseases Department, France. Electronic address: yazdan.yazdanpanah@inserm.fr.
Clin Microbiol Infect ; 28(1): 1-5, 2022 01.
Article in English | MEDLINE | ID: covidwho-1611665
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adaptive Clinical Trials as Topic / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.cmi.2021.10.011

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adaptive Clinical Trials as Topic / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.cmi.2021.10.011